Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management

CCLA Investment Management grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 1.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,047,488 shares of the medical research company’s stock after purchasing an additional 19,518 shares during the quarter. Agilent Technologies makes up about 2.3% of CCLA Investment Management’s portfolio, making the stock its 14th biggest holding. CCLA Investment Management owned approximately 0.37% of Agilent Technologies worth $142,542,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in A. Capital A Wealth Management LLC boosted its stake in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the last quarter. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies during the 4th quarter valued at about $27,000. Davis Capital Management acquired a new position in shares of Agilent Technologies during the 3rd quarter valued at about $28,000. Physician Wealth Advisors Inc. boosted its position in shares of Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 196 shares during the last quarter. Finally, State of Wyoming acquired a new position in shares of Agilent Technologies during the 2nd quarter valued at about $35,000.

Wall Street Analysts Forecast Growth

A has been the topic of several analyst reports. TD Cowen reduced their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. UBS Group reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Price Performance

A stock opened at $116.90 on Thursday. The company has a market capitalization of $33.04 billion, a P/E ratio of 25.81, a PEG ratio of 2.43 and a beta of 1.30. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27. The business has a 50 day simple moving average of $120.08 and a 200-day simple moving average of $134.24. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period in the previous year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.